Release of Biogenic Amines from Isolated Nerve Endings

  • Maurizio Raiteri
  • Alberto Bertollini
  • Renata del Carmine
  • Giulio Levi
Part of the Advances in Experimental Medicine and Biology book series (AEMB)


Two essential biochemical steps of the aminergic neurotransmission are the release of the neurotransmitter and its reuptake by presynaptic nerve terminals. Many neuroactive drugs are believed to modify the availability of the neurotransmitter amines in the synaptic cleft by interacting with these processes 8, 10, 14, 20, 23.


Biogenic Amine Fraction Number Corpus Striatum Synaptosomal Preparation Cortical Synaptosome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Axelrod, J. and Saavedra, M.J., Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain, Ciba Foundation Symp.,22 (1974) 51–59.Google Scholar
  2. 2.
    Azzaro, A.J., Ziance, R.J. and Rutledge, C.O., The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue, J. Pharmacol, exp. Ther., 189 (1974) 110–118.Google Scholar
  3. 3.
    Baldessarini, R.J. and Kopin I.J., The effect of drugs on the release of norepinephrine-H from central nervous system tissues by electrical stimulation in vitro, J. Pharmacol. exp. Ther., 156 (1967) 31–38.Google Scholar
  4. 4.
    Besson, M.J., Cheramy, A., Feltz, P. and Glowinski, J., Release of newly synthetized dopamine from dopamine-containing terminals in the striatum of the rat, Proc. Nat. Acad. Sci. (USA), 62 (1969) 741–748.CrossRefGoogle Scholar
  5. 5.
    Besson, M.J., Cheramy, A., Feltz, P. and Glowinski, J., Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat, Brain Res., 32 (1971) 407–424.CrossRefGoogle Scholar
  6. 6.
    Blaustein, M.P., Johnson, E.M. and Needleman, P., Calcium-de- pendent norepinephrine release from presynaptic nerve endings in vitro, Proc. Nat. Acad. Sci. (USA), 69 (1972) 2237–2240CrossRefGoogle Scholar
  7. 7.
    Boakes, R.J., Bradley, P.B. and Candy, J.M., A neuronal basis for the alerting action of (+)-amphetamine, Brit. J. Pharmacol., 45 (1972) 391–403.Google Scholar
  8. 8.
    Bopp, B. and Biel, J.H., Antidepressant drugs. Life Sci., 14 (1974) 415–423.CrossRefGoogle Scholar
  9. 9.
    Boulton, A.A., Amines and theories in psychiatry. The Lancet, July 6 (1974) 52–53.CrossRefGoogle Scholar
  10. 10.
    Carlsson, A;, Effect of drugs on amine uptake mechanisms in the brain. In H.J. Schumann and G. Droneberg (Eds.) New Aspects of storage and release mechanisms of catecholamines, Springer-Verlag, Berlin, 1970, pp. 223–233.CrossRefGoogle Scholar
  11. 11.
    Carlsson, A., Amphetamine and brain catecholamines. In E. Costa and S. Garattini (Eds.) Amphetamines and related compounds. Raven Press, New York, 1970, pp. 289–300.Google Scholar
  12. 12.
    Carr, L.A. and Moore, K.E., Norepinephrine: release from brain by d-amphetamine in vivo. Science 164 (1969) 322–323.CrossRefGoogle Scholar
  13. 13.
    Colburn, R.W. and Kopin, I.J., Effects of reserpine and tyra- mine on release of norepinephrine from synaptosomes, Biochem. Pharmacol., 21 (1972) 733–736.CrossRefGoogle Scholar
  14. 14.
    Coyle, J.T. and Snyder, S.H., Antiparkinsonism drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science, 166 (1969) 899–901.CrossRefGoogle Scholar
  15. 15.
    De Belleroche, J.S. and Bradford, H.F., Metabolism of beds of mammalian synaptosomes and their response to depolarizing influences, J. Neurochem., 19 (1972) 585–602.CrossRefGoogle Scholar
  16. 16.
    Douglas, W.W., Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. The first Gaddum memorial lecture, Brit. J. Pharmacol., 34 (1968) 451–474.Google Scholar
  17. 17.
    Ferris, M.R., Tang, F.L.M. and Maxwell, R.A., A comparison of the capacities of isomers of amphetamine, deoxypipradol and me- thylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol, exp. Ther., 181 (1972) 407–416.Google Scholar
  18. 18.
    Glowinski, J. and Axelrod J., Effects of drugs on the uptake, release and metabolism of 3H-norepinephrine in the rat brain, J. Pharmacol, exp. Ther., 149 (1965) 43–49.Google Scholar
  19. 19.
    Glowinski, J., Storage and release of monoamines in the central nervous system. In A. Lajtha (Ed.) Handbook of Neurochemistry vol. 3, Plenum Press, New York, 1970, pp. 91–114.Google Scholar
  20. 20.
    Horn, A.S., Coyle, J.T. and Snyder, S.H., Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons, Mol. Pharmacol., 7 (1971) 66–80.Google Scholar
  21. 21.
    Iversen, L.L., Neuronal uptake processes for amines and amino acids. In E. Costa and E. Giacobini (Eds.) Biochemistry of Simple Neuronal Models. Advances in Biochemical Psychopharmacology, vol. 2, Raven Press, New York, 1970, pp. 109–132.Google Scholar
  22. 22.
    Iversen, L.L., Catecholamine uptake processes, Brit. Med. Bull., 29 (1973) 130–135.Google Scholar
  23. 23.
    Kannengiesser, M.H., Hunt, P. and Raynaud, J.P., An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity, Biochem. Pharmacol., 22, (1973) 73–84.CrossRefGoogle Scholar
  24. 24.
    Ng, K.Y., Chase, T.N. and Kopin, I.J., Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices. Nature, 228 (1970) 468–469.CrossRefGoogle Scholar
  25. 25.
    Raiteri, M. and Levi, G., Antisynaptosome antibodies affect synaptosomal permeability to neurotransmitters. Nature New Biol., 245 (1973) 89–91.CrossRefGoogle Scholar
  26. 26.
    Raiteri, M., Angelini, F. and Levi, G., A simple apparatus for studying the release of neurotransmitters from synaptosomes, Eur. J. Pharmacol., 25 (1974) 411–414.CrossRefGoogle Scholar
  27. 27.
    Raiteri, M., Levi, G. and Federico, R., d-Amphetamine and the release of 3H-norepinephrine from synaptosomes, Eur. J. Pharmacol., 28 (1974) 237–240.CrossRefGoogle Scholar
  28. 28.
    Raiteri, M., Federico, R., Coletti, A. and Levi G., Release and exchange studies relating to the synaptosomal uptake of GABA, J. Neurochem., 24 (1975) 1243–1250.CrossRefGoogle Scholar
  29. 29.
    Raiteri, M., Bertollini, A., Angelini, F. and Levi, G., d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes, Eur. J. Pharmacol., 34 (1975) (in press).Google Scholar
  30. 30.
    Raiteri, M., Levi, G. and Federico R., Stimulus-coupled release of unmetabolized -3H-norepinephrine from rat brain synaptosomes, Pharmacol. Res. Comm., 7 (1975) 181–187.CrossRefGoogle Scholar
  31. 31.
    Sabelli, H.C. and Mosnaim, A.D., Phenylethylamine hypothesis of affective behaviour. Am. J. Psychiatry, 131 (1974) 695–699.Google Scholar
  32. 32.
    Snyder, S.H., Kuhar, M.J., Green, A.I., Coyle, J.T. and Shaskan, E.G., Uptake and subcellular localization of neurotransmitters in the brain. Int. Rev. Neurobiol., 13 (1970) 127–157.CrossRefGoogle Scholar
  33. 33.
    Thierry, A.M., Blanc, G., Sobel, A., Stinus, L. and Glowinski, J., Dopaminergic terminals in the rat cortex. Science, 182 (1973) 499–501.CrossRefGoogle Scholar
  34. 34.
    Von Voigtlander, P.F. and Moore, K.E., Involvement of nigro-stri- atal neurons in the vivo release of dopamine by amphetamine, amantadine and tyramine, J. Pharmacol, exp. Ther., 184 (1973) 542–552.Google Scholar
  35. 35.
    Weinshilbaum, R.M., Thoa, N.B., Johnson, D.G., Kopin, I.J. and Axelrod, J., Proportional release of norepinephrine and dopamine- β -hydroxylase from sympathetic nerves. Science, 174 (1971) 1349–1351.CrossRefGoogle Scholar
  36. 36.
    Ziance, R.J., Azzaro, A.J. and Rutledge, C.O., Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro, J. Pharmacol, exp. Ther., 182 (1972) 284–294.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Maurizio Raiteri
    • 1
  • Alberto Bertollini
    • 1
  • Renata del Carmine
    • 1
  • Giulio Levi
    • 2
  1. 1.Institute of PharmacologyCatholic UniversityRomeItaly
  2. 2.Laboratory of Cell BiologyCNRRomeItaly

Personalised recommendations